Nils Hartmannn
Selbstständig, Selbständiger Berater und Interim Manager, Hartmann Pharma Consulting
Zürich, Schweiz
Über mich
Successful, internationally experienced Senior Executive in the pharmaceutical industry. Strong across the entire value chain, starting from strategy definition to successful execution. 25 years of experience in marketing and sales with an established track record of engaging, coaching, and developing individuals and organizations. Impactful leadership resulting from high engagement and performance orientation. Erfolgreiche, international erfahrene Führungskraft in der pharmazeutischen Industrie. Stark auf der gesamten Wertschöpfungskette, angefangen bei der Strategiedefinition bis hin zur erfolgreichen Umsetzung. 25 Jahre Erfahrung in Marketing & Verkauf, sowie dem Coaching und der Entwicklung von Mitarbeitern* und Organisationen. Hohes Engagement, Leistungsorientierung und Führungsstärke.
Werdegang
Berufserfahrung von Nils Hartmannn
Bis heute 3 Monate, seit März 2024
Selbständiger Berater und Interim Manager
Hartmann Pharma Consulting
Interim-Management Lösungen und Beratungsprojekte für Pharmaunternehmen.
3 Jahre und 10 Monate, März 2020 - Dez. 2023
President & General Manager Poland at Eli Lilly and Company
Eli Lilly & Company
Head of Lilly's business operations in Poland with revenue of $128M and 140 employees. Accelerated affiliate revenue growth from historically 6-7% to 45% through successful expansion of product reimbursement and new product launches.
2 Jahre und 1 Monat, Feb. 2018 - Feb. 2020
Asscociate Vice President, Global Marketing | Diabetes
Eli Lilly & Company
Head of global product strategy; responsible for the definition and execution of the global marketing strategy for Trulicity (type II diabetes; $7.4B sales in 2022). Successful Trulicity launch in China, including obtaining reimbursement. Lead for the strategy definition, launch readiness, and drug approval (FDA, EMA & PMDA) of BAQSIMI (inhalable nasal Glucagon).
11 Monate, Apr. 2017 - Feb. 2018
International Therapeutic Area Leader Diabetes (Associate Vice President)
Eli Lilly and Company
Ensured correct implementation of global brand strategies in all international markets (except US/Canada) and consulted affiliates on priorities and correct implementation. Defined competitive launch strategy for Lilly insulin biosimilars.
4 Jahre und 6 Monate, Okt. 2012 - März 2017
Business Unit Lead Diabetes (Associate VP) for Germany, Austria & Switzerland
Lilly Deutschland GmbHHead of Lilly’s diabetes commercial operations in Germany, Austria, and Switzerland. First market outside the US to launch Trulicity, Jardiance, Basaglar, Humalog 200 with best-in-class launch uptakes. Extensive collaboration with Boehringer Ingelheim and Berlin Chemie.
Led 3 sales teams with 11 district sales managers and 87 sales representatives. Significant performance improvement for the two hospital sales teams (cardiology and pulmonary arterial hypertension) while exceeding revenue targets with the retail sales team (osteoporosis & erectile dysfunction).
Head of brand management for Byetta (type II diabetes). Successfully executed competitive strategy against a new market entrant.
Led 10 sales representatives. Improved district ranking with Zyprexa (schizophrenia & bipolar disorder) and Cymbalta (depressive and anxiety disorder) in 2007 and with Forsteo (osteoporosis) and Cymbalta in 2008/09.
Defined, implemented, and tracked affiliate priorities for executive team. Ran market research to identify weaknesses in the offered Continuous Medical Education (CME) and successfully launched new educational concepts. Repositioned and supervised a service force of 10 for nutritional consulting.
1999 - 2004
Senior Brand Manager and Category Development Manager
Unilever Schweiz
Launched the Dove hair care portfolio, strengthened Rexona's position in the deodorant category, and repositioned the male grooming brand Axe.
1997 - 1997
Trainee
B.Braun Medical
Ausbildung von Nils Hartmannn
2004 - 2005
Economics
INSEAD, MBA Programm
Projekt Managment, Führung, Marketing
1994 - 1998
Finanz- und Rechnungswesen
Universität St. Gallen (HSG)
Business Administration/Economics; Vertiefung Finanz- und Rechnungswesen, Marketing
Sprachen
Deutsch
Muttersprache
Englisch
Fließend
Französisch
Grundlagen
Spanisch
Grundlagen